Skip to content
Dx

ICD-10-PCS 2027 procedure code

3E09XGCIntroduction of Other Therapeutic Substance into Nose, External Approach

✓ Valid for 2027

Short description: Introduction of Oth Therap Subst into Nose, Extern Approach

Code unchanged since ICD-10-PCS took effect on October 1, 2015. Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data

About 3E09XGC

3E09XGC is the ICD-10-PCS code for a introduction procedure on the nose using an external approach with other therapeutic substance (qualifier: other substance). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

In plain terms, this corresponds to control of epistaxis by cauterization (and packing), the ICD-9-CM procedure title it maps to (21.03).

For a different body part, codes include 3E00XGC (skin and mucous membranes), 3E0BXGC (ear), 3E0CXGC (eye) and 3E0DXGC (mouth and pharynx).

The same procedure with a different approach is coded 3E093GC (percutaneous) and 3E097GC (via natural or artificial opening).

It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.

It has been valid since ICD-10-PCS took effect on October 1, 2015.

What each character means

1. Section
3Administration
2. Body System
EPhysiological Systems and Anatomical Regions
3. Operation
0Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4. Body System / Region
9Nose
5. Approach
XExternal

Procedures performed directly on the skin or mucous membrane and procedures performed indirectly by the application of external force through the skin or mucous membrane

6. Substance
GOther Therapeutic Substance

Includes: Anacaulase-bcdb; Bromelain-enriched Proteolytic Enzyme; Collagenase SANTYL Ointment; COSELA(tm) (Trilaciclib); ENSPRYNG(tm) (Satralizumab-mwge); Fostamatinib; Idarucizumab, Pradaxa(R)(dabigatran) reversal agent; NexoBrid(tm); Praxbind(R) (idarucizumab), Pradaxa(R)(dabigatran) reversal agent; SANTYL Ointment; Satralizumab-mwge; TAVALISSE(R); Trilaciclib

7. Qualifier
COther Substance

Other versions of this procedure

ICD-9-CM equivalent

Converter →
  • 21.03Control of epistaxis by cauterization (and packing)approximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about 3E09XGC

Is 3E09XGC a valid ICD-10-PCS code for 2027?

Yes. 3E09XGC is valid for inpatient procedures from October 1, 2026 through September 30, 2027.

What is the ICD-9 procedure code for 3E09XGC?

The CMS GEMs map 3E09XGC to ICD-9-CM 21.03 (Control of epistaxis by cauterization (and packing)).